Full Text View
Tabular View
No Study Results Posted
Related Studies
Surface Nerve Stimulation Treatment for OAB in Children
This study has been completed.
Study NCT00282490   Information provided by University of Aarhus
First Received: January 25, 2006   Last Updated: June 13, 2008   History of Changes

January 25, 2006
June 13, 2008
February 2006
March 2008   (final data collection date for primary outcome measure)
Clinical effects evaluated by home registrations of degree of incontinence, VAS score of degree of urgency and frequency volume charts at specified intervals. Acute effect evaluated by urodynamics.
Same as current
Complete list of historical versions of study NCT00282490 on ClinicalTrials.gov Archive Site
Bladder capacity, voiding frequency and subjective impression of incontinence.
Same as current
 
Surface Nerve Stimulation Treatment for OAB in Children
Sacral Transcutaneous Nerve Stimulation Treatment for Functional Daytime Incontinence in Children With Over Active Bladder Syndrome

The purpose of this study is to perform a randomized controlled investigation of the effect of surface nerve stimulation on functional daytime incontinence in children with OAB.

Daytime urinary incontinence is common in children. At the age of 7 a prevalence of 2-9 % has been reported. Daytime urinary incontinence is a heterogenic multifactorial illness where the the symptoms has several degrees of severity and can be caused by different mechanisms. Daytime urinary incontinence can be etiologically classified in the rare neurogenic and structural forms and the common functional or idiopathic form (where no neurological or structural cause of the bladder dysfunction can be identified.

The symptom based diagnosis OAB (overactive bladder) is most often used to describe daytime urinary incontinence in children. OAB is defined as a symptom syndrome including urgency with or without urge incontinence in combination with frequency.

When urinary tract infection and neurogenic and structural causes has been excluded the nonpharmacological bladder rehabilitation is first line treatment of OAB. It is expected that approximately 50 % of the children can be relieved of symptoms by this treatment. In the non-responding cases behavioural modifying regimes can be coupled with anticholinergic medication. However, poor compliance of the child or parents, or dose limiting side effects often influences the efficacy of this intervention. Also a considerable number of children experience no or only limited effect from the treatment even though all instructions are complied with. This has let to research into new treatment modalities and the use of low frequency electrical current to inhibit detrusor overactivity in adults has become common. Pilot studies have indicated a significant effect of TENS on urinary incontinence in children with OAB.

Hypothesis:

  • Sacral TENS is an effective treatment of urinary incontinence in children with OAB refractory to anticholinergic medication coupled with bladder training and voiding reeducation.
  • The acute effect of sacral TENS can be identified by urodynamics
  • It is possible to predict the outcome of sacral TENS treatment in these children.

    30 children (age 5-14 years) with functional daytime incontinence refractory to anticholinergic medication coupled with bladder training. The study protocol consists of 1 week of basic home registrations and a 4 day in-patient phase succeeded by a 4 week home training period. The participants will be randomized to treatment with either active or inactive TENS.

 
Interventional
Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
  • Overactive Bladder
  • Urinary Incontinence
Device: Nerve stimulator
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
30
March 2008
March 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Daytime urinary incontinence with at least 1 episode of at least 1 ml per week
  • Incontinence refractory to treatment
  • Informed consent

Exclusion Criteria:

  • Severe diseases of the kidneys or urinary tract besides OAB
Both
5 Years to 15 Years
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00282490
 
SHTENS2006, 2006-41-6085,, 20050180
University of Aarhus
 
Principal Investigator: Soeren Hagstroem, MD University of Aarhus
University of Aarhus
June 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP